Andere Sprachen Wave Life Sciences Ltd.

Aktien

A1436W

SG9999014716

WVE

Markt geschlossen - Nasdaq Andere Börsenplätze 22:00:00 17.05.2024			% 5 Tage	% 1. Jan.
6,26 ^USD	+6,10 %		+11,39 %	+23,96 %

15.05.	WAVE LIFE SCIENCES LTD. : Bewertung von Wells Fargo Securities zum Kaufen erhalten	ZM
09.05.	Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Wave Life Sciences : Potent, Durable mRNA Knockdown in Extrahepatic Tissues Using siRNAs With Novel Phosphoryl Guanidine Backbone Variants	10.05.
Wave Life Sciences : Chemical Design of Oligonucleotides That Support Targeted RNA Editing in the CNS of Non-Human Primates	10.05.
Earnings Flash (WVE) WAVE LIFE SCIENCES USA Posts Q1 Revenue $12.5M, vs. Street Est of $23M	09.05.
Wave Life Sciences: Q1 Earnings Snapshot	09.05.
Wave Life Sciences Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	09.05.
Wave Life Sciences Reports First Quarter 2024 Financial Results and Provides Business Update	09.05.
Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer	09.05.
Wave Life Sciences Announces Appointment of Erik Ingelsson as Chief Scientific Officer	09.05.
Wave Life Sciences to Present at 2024 RBC Capital Markets Global Healthcare Conference	07.05.
Wave Life Sciences First Quarter 2024 Financial Results Scheduled for May 9, 2024	02.05.
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency (AATD)	30.04.
Wave Life Sciences Announces Approval of First Clinical Trial Application for RestorAATion-2 Trial of WVE-006 in Individuals with Alpha-1 Antitrypsin Deficiency	30.04.
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing	23.04.
Wave Life Sciences Ltd. Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing	23.04.
Wave Life Sciences to Present at Upcoming Investor Conferences	27.03.
Sector Update: Health Care Stocks Higher Late Afternoon	06.03.
WAVE Life Sciences Shares Surge After Q4 Beats Estimates	06.03.
Wave Life Sciences: Q4 Earnings Snapshot	06.03.
Wave Life Sciences Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	06.03.
Wave Life Sciences Ltd. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	06.03.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Wave Life Sciences Ltd.

Aktien

A1436W

SG9999014716

WVE

Andere Sprachen

Filter